TC
ACHV icon

TFS Capital’s Achieve Life Sciences ACHV Stock Holding History

TFS Capital’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-31
Closed -$47K – 943
2016
Q1 		$47K Sell
31
-22
-42% -$35.8K 0.01% 953
2015
Q4 		$141K Sell
53
-79
-60% -$334K 0.02% 620
2015
Q3 		$649K Buy
132
+42
+47% +$253K 0.06% 446
2015
Q2 		$461K Buy
+90
New +$446K 0.05% 560
2014
Q4 		– Sell
-58
Closed -$341K – 965
2014
Q3 		$341K Sell
58
-106
-65% -$736K 0.03% 712
2014
Q2 		$1.34M Buy
164
+81
+98% +$995K 0.11% 305
2014
Q1 		$2.15M Buy
83
+56
+207% +$1.38M 0.14% 209
2013
Q4 		$492K Buy
+27
New +$474K 0.02% 838

Other funds holding ACHV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TFS Capital's ACHV Position: Q2 2016 in Review

TFS Capital sold out of Achieve Life Sciences (ACHV) in Q2 2016, closing a stake of 31 shares — an estimated $47K sold.

TFS Capital first reported a position in ACHV in Q4 2013 and held it in 8 quarters. The position peaked at $2.15M in Q1 2014. 34 funds tracked by Wall St. Rank hold ACHV as of Q2 2016.

  • TFS Capital reported no remaining Achieve Life Sciences position as of Q2 2016 after selling out during the quarter.
  • TFS Capital sold 31 Achieve Life Sciences shares in Q2 2016, an estimated $47K.
  • TFS Capital first reported a position in Achieve Life Sciences in Q4 2013 and held it in 8 quarters.
  • TFS Capital's Achieve Life Sciences position peaked at $2.15M in Q1 2014.
  • 34 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2016.

Based on TFS Capital's 13F filing for Q2 2016, filed 11 Aug 2016.